ACR open rheumatology · 2025
Effects of Audio-Guided Imagery on Raynaud Phenomenon in Connective Tissue Disease.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Padilla Cristina, Katikineni Veena, Park Yongseok, Freno Leigh, Laffoon Maureen, Reichbaum Lee, Lafyatis Robert, Domsic Robyn
Аннотация
OBJECTIVE: To assess the physical, emotional, and mental impact of regular audio-guided imagery (AGI) in patients with connective tissue disease (CTD)-associated Raynaud phenomenon (RP).
METHODS: Sixteen adult patients with CTD-associated RP were enrolled in an open-label, single-arm, eight-week intervention with daily AGI at a single center. Patients completed surveys, including assessment of RP severity, depression/anxiety, and quality of life at baseline and the end of eight weeks.
RESULTS: Study participants demonstrated significant improvement in all patient reported outcomes, except Generalized Anxiety Disorder 7, which showed improvement but was not statistically significant. This eight-week intervention shows that patients with CTD-associated RP had less severe RP episodes, as well as improved quality of life and depressive symptoms.
CONCLUSION: AGI significantly improved several domains of health, including physical, emotional, and mental, in patients with CTD-associated RP who otherwise more commonly struggle with more RP attacks, lower quality of life, and depression. AGI is a low-cost, low-risk, and convenient therapy for CTD-associated RP. A larger study studying the effects of this intervention is indicated.
METHODS: Sixteen adult patients with CTD-associated RP were enrolled in an open-label, single-arm, eight-week intervention with daily AGI at a single center. Patients completed surveys, including assessment of RP severity, depression/anxiety, and quality of life at baseline and the end of eight weeks.
RESULTS: Study participants demonstrated significant improvement in all patient reported outcomes, except Generalized Anxiety Disorder 7, which showed improvement but was not statistically significant. This eight-week intervention shows that patients with CTD-associated RP had less severe RP episodes, as well as improved quality of life and depressive symptoms.
CONCLUSION: AGI significantly improved several domains of health, including physical, emotional, and mental, in patients with CTD-associated RP who otherwise more commonly struggle with more RP attacks, lower quality of life, and depression. AGI is a low-cost, low-risk, and convenient therapy for CTD-associated RP. A larger study studying the effects of this intervention is indicated.